>> Black Swan Analysis Blog

Black Swan Analysis Blog

NHS announces £300 million saved by switching to best value biologics as part of 10-year plan

On October 08, 2019, Tags Pricing Strategies


World Mental Health Day

On October 07, 2019, Tags News

World Mental Health Day

The Rise of Artificial Intelligence (AI) in Clinical Trials

On October 04, 2019,


Onco-Strat News

On October 02, 2019, Tags Oncology

All cancers are genomic diseases, and with the advent of time efficient and more widely affordable genome sequencing technology, the study into similarities between cancer specific gene mutations has...

New Project Update

On September 27, 2019, Tags News

The latest internally developed BSA online platform is a pharmaceutical product lifecycle database which will allow the user to assess the competitive landscape for a selected active substance,...

Onco-Strat Product Update

On September 25, 2019, Tags Oncology

Over the past year the Onco-Strat team has been growing, and with greater analyst investment comes a greater scope of platform functionality, bringing additional value for subscribers. The latest...

Global surge in measles cases

On September 23, 2019,

The World Health Organisation (WHO) officially declared that measles had been eradicated in the UK in 2017. Less than three years later and that eradication status has been revoked, as well as in...

A New Era of Contraception

On July 18, 2019, Tags Medicine

With an ever-growing societal attitude of equality and the push forward towards feminism, there is a desire for the development of a male contraception in order to have both individual and shared...

Challenges surrounding CNS drug discovery

On July 11, 2019, Tags Medicine

The central nervous system (CNS) compromises the brain and spinal cord and is the most complex system in the human body; consisting of an estimated 100 billion neurons, each connected to thousands...

Pharmaceutical Pricing Challenges; USA perspective

On July 04, 2019, Tags Pricing Strategies

The pharmaceutical pricing landscape is by the most convoluted system and the main culprit of this is the USA. The pricing structure of the pharmaceuticals is by no means transparent and requires...

New Call-to-action

Subscribe to Email Updates

New call-to-action
RX Brochure CTA Large

Recent Posts

Free Brochure Epiomic